In vitro studies have further shown that KIT expression can be induced by interleukin-3 (IL-3) and erythropoietin (EPO), with or without stem cell factor (SCF) expression on cell isolated from MDS patients [30]. This evidence concerns the gene KITLG and myelodysplastic syndrome.